dacarbazine has been researched along with Zollinger-Ellison Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosotani, R; Imamura, M; Kubota, N; Ochi, J; Ohshio, G; Sakahara, H | 1 |
| Benson, JB; Ferrara, JJ; Fucci, JC | 1 |
2 other study(ies) available for dacarbazine and Zollinger-Ellison Syndrome
| Article | Year |
|---|---|
Gastrinoma with multiple liver metastases: effectiveness of dacarbazine (DTIC) therapy.
Topics: Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Gastrinoma; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Zollinger-Ellison Syndrome | 1998 |
Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion.
Topics: Adenoma, Islet Cell; Dacarbazine; Gastrins; Glucagon; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Zollinger-Ellison Syndrome | 1985 |